NEW YORK LIFE INVESTMENT MANAGEMENT LLC
Q4 2023 13F-HR Holdings
Net value change ($000)
+510,827
(5.5%)
New positions
83
Sold out positions
65
Turnover %
9.4%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q3 2023
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| New York Life Investments ETF Trust | 132,297 | NEW |
| MSFT | 66,876 | 18.2% |
| AAPL | 45,738 | 11.7% |
| AMZN | 36,008 | 20.0% |
| IQSM | 27,233 | 16.3% |
| AGG | 23,023 | 118.6% |
| WestRock Co | 20,613 | 912.5% |
| ImmunoGen, Inc. | 20,233 | NEW |
| SPLUNK INC | 20,141 | 4830.0% |
| AHC | 19,919 | 316.5% |
Top Reduces (Value $000, Stocks/ETFs)
| New York Life Investments ETF Trust | -229,250 | -100.0% |
| Abcam plc | -34,893 | -100.0% |
| Horizon Therapeutics Public Ltd Co | -31,009 | -100.0% |
| DENBURY INC | -30,980 | -100.0% |
| Seagen Inc. | -30,613 | -100.0% |
| New York Life Investments ETF Trust | -22,706 | -100.0% |
| SCHZ | -19,407 | -100.0% |
| COMT | -18,945 | -78.1% |
| CPRI | -17,470 | -50.0% |
| NEW RELIC, INC. | -16,333 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|